Factors influencing the transition from prediabetes to diabetes on Reunion Island
Study of the Factors Favoring the Transition From Prediabetes to Diabetes on Reunion Island. Impact of the "Say No to Diabetes" Intervention.
This study is trying to find out what causes prediabetes to turn into diabetes in people aged 25 to 70 on Reunion Island and will include a program to help prevent this change.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 2000 (estimated) |
| Ages | 25 Years to 70 Years |
| Sex | All |
| Sponsor | Centre Hospitalier Universitaire de la Réunion Academic / other |
| Locations | 1 site (Saint-Pierre) |
| Trial ID | NCT04463160 on ClinicalTrials.gov |
What this trial studies
This study focuses on understanding the factors that contribute to the progression from prediabetes to diabetes among the population of Reunion Island, where diabetes prevalence is notably high. It involves a prevention program called 'Say No to Diabetes' aimed at individuals aged 25 to 70 who are diagnosed with prediabetes. Participants will be monitored and surveyed to gather data on their health status and the effectiveness of the intervention. The study seeks to address the urgent health crisis posed by diabetes in this region.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals aged 25 to 70 with prediabetes as defined by specific blood sugar levels.
Not a fit: Patients who have already been diagnosed or treated for diabetes, except for gestational diabetes, will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to effective prevention strategies that reduce the incidence of diabetes and its complications in the Reunion Island population.
How similar studies have performed: While there have been various studies on diabetes prevention, this specific approach tailored to the unique demographic and health challenges of Reunion Island is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Subject aged 25 to 70 with pre-diabetes defined by fasting blood sugar between 1.10 and 1.25 g / l (6.1 and 6.9 mmol / l) or blood sugar between 1.40 and 1.99 g / l (7.8 and 11.0 mmol / l) 2 hours after taking 75g of glucose (HGPO test), dating from less than 3 months. * Consulting one of the general practitioners involved in the study, whatever the initial reason for the consultation * able to answer a telephone survey questionnaire * who have never been diagnosed or treated for diabetes with the exception of gestational diabetes * Person affiliated or beneficiary of a social security scheme. * Free, informed and written consent signed Exclusion Criteria: * People likely to leave Reunion within 2 years * Persons placed under guardianship, curators, safeguard of justice, person participating in another research including an exclusion period still in progress. * Person with severely impaired physical and / or psychological health, who, according to the investigator, may affect the compliance of the study participant. * Pregnancy in progress
Where this trial is running
Saint-Pierre
- Centre Hospitalier Universitaire de la Réunion — Saint-Pierre, France (Recruiting)
Study contacts
- Study coordinator: Samir MEDJANE
- Email: samir.medjane@chu-reunion.fr
- Phone: 0262359750
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.